Purple Biotech (PPBT) Operating Leases (2015 - 2025)
Purple Biotech (PPBT) posted quarterly Operating Leases of $244000.0 for Q4 2025, up 33.33% year-over-year from $183000.0 in Q4 2024, and up 33.33% quarter-over-quarter from $183000.0 in Q4 2024.
Purple Biotech (PPBT) Operating Leases (2015 - 2025) Analysis & Trends
Purple Biotech (PPBT) has reported Operating Leases for 11 consecutive years, with $244000.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Operating Leases rose 33.33% year-over-year to $244000.0; the TTM figure through Dec 2025 stood at $244000.0 (up 33.33% YoY), while the FY2025 annual figure was $244000.0, up 33.33% from the prior year.
- Operating Leases climbed to $244000.0 in Q4 2025 per PPBT's latest filing, from $183000.0 in the prior quarter.
- Across five years, Operating Leases topped out at $877000.0 in Q4 2021 and bottomed at $38000.0 in Q3 2024.
- Historically, Operating Leases has averaged $339647.1 across 5 years, with a median of $278000.0 in 2023.
- Annual changes were most pronounced in 2021 — Operating Leases jumped 7462.5% — and 2024, when it slumped 80.21%.
- Purple Biotech's Operating Leases stood at $877000.0 in 2021, then plunged by 63.4% to $321000.0 in 2022, then sank by 49.22% to $163000.0 in 2023, then advanced by 12.27% to $183000.0 in 2024, then jumped by 33.33% to $244000.0 in 2025.
- Business Quant data shows PPBT's Operating Leases at $244000.0 in Q4 2025, $183000.0 in Q4 2024, and $38000.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.41 Bn | 131.56 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.14 Bn | 78.15 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.52 Bn | 60.34 Bn | 1.37 Bn |
| 4 | Moderna | 58.21 Bn | 53.07 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.15 Bn | 37.05 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.62 Bn | 28.31 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.95 Bn | 9.56 Bn | 668.28 Mn |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.30 Bn | 26.46 Bn | - |
| 10 | Purple Biotech | 127.07 | 127.07 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 244,000.00 |
| Dec 31, 2024 | 183,000.00 |
| Sep 30, 2024 | 38,000.00 |
| Jun 30, 2024 | 79,000.00 |
| Mar 31, 2024 | 121,000.00 |
| Dec 31, 2023 | 163,000.00 |
| Sep 30, 2023 | 192,000.00 |
| Jun 30, 2023 | 237,000.00 |
| Mar 31, 2023 | 278,000.00 |
| Dec 31, 2022 | 321,000.00 |
| Sep 30, 2022 | 357,000.00 |
| Jun 30, 2022 | 399,000.00 |
| Mar 31, 2022 | 495,000.00 |
| Dec 31, 2021 | 877,000.00 |
| Sep 30, 2021 | 563,000.00 |
| Jun 30, 2021 | 605,000.00 |
| Mar 31, 2021 | 622,000.00 |
| Dec 31, 2020 | 1.05 Mn |
| Jun 30, 2020 | 8,000.00 |
| Dec 31, 2019 | 28,000.00 |